标题
Is Individualized Medicine More Cost-Effective? A Systematic Review
作者
关键词
Human Epidermal Growth Factor Receptor, Idiopathic Pulmonary Fibrosis, Lynch Syndrome, MeSH, National Comprehensive Cancer Network
出版物
PHARMACOECONOMICS
Volume 32, Issue 5, Pages 443-455
出版商
Springer Nature
发表日期
2014-02-26
DOI
10.1007/s40273-014-0143-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- (2013) Uri Ladabaum et al. ANNALS OF INTERNAL MEDICINE
- Review of the Cost Effectiveness of Pharmacogenetic-Guided Treatment of Hypercholesterolaemia
- (2013) Michael J. Sorich et al. PHARMACOECONOMICS
- Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan
- (2012) Masahide Kondo et al. BREAST CANCER RESEARCH AND TREATMENT
- Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
- (2012) Nathan W. D. Lamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
- (2012) Calogero Cammà et al. HEPATOLOGY
- Endogenous cost-effectiveness analysis and health care technology adoption
- (2012) Anupam B. Jena et al. JOURNAL OF HEALTH ECONOMICS
- Personalized oncology: Recent advances and future challenges
- (2012) Madhu Kalia METABOLISM-CLINICAL AND EXPERIMENTAL
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
- (2011) Valesca P. Retèl et al. BREAST CANCER RESEARCH AND TREATMENT
- KRAS and BRAF Mutation Analysis in Metastatic Colorectal Cancer: A Cost-effectiveness Analysis from a Swiss Perspective
- (2011) P. R. Blank et al. CLINICAL CANCER RESEARCH
- A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy
- (2011) Jodie Ingles et al. HEART
- Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
- (2011) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Testing Women With Endometrial Cancer to Detect Lynch Syndrome
- (2011) Janice S. Kwon et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer
- (2011) Peter S. Hall et al. JNCI-Journal of the National Cancer Institute
- Economic Opportunities and Challenges for Pharmacogenomics
- (2010) Patricia A. Deverka et al. Annual Review of Pharmacology and Toxicology
- Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population
- (2010) T. A. Dinh et al. Cancer Prevention Research
- Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
- (2010) Marco V. Perez et al.
- Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
- (2010) Valesca P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
- (2010) Mercy Mvundura et al. GENETICS IN MEDICINE
- Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis
- (2010) Jared T. Hagaman et al. LUNG
- Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
- (2010) Rena Conti et al. MEDICAL DECISION MAKING
- Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
- (2010) D. T. Tsoi et al. ONCOLOGIST
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
- (2010) Shmuel H. Klang et al. VALUE IN HEALTH
- Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
- (2009) J H S You et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
- (2009) Roy H Perlis et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes
- (2009) Stefan Vegter et al. PHARMACOECONOMICS
- 30 Years of Pharmaceutical Cost-Utility Analyses
- (2009) Peter J. Neumann et al. PHARMACOECONOMICS
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
- (2009) Lisa M. Meckley et al. PHARMACOECONOMICS
- Pharmacogenomics and Public Health
- (2009) D. Veenstra et al. Public Health Genomics
- Pharmacogenomics, Evidence, and the Role of Payers
- (2009) P.A. Deverka Public Health Genomics
- Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
- (2008) Arthi Vijayaraghavan et al. GYNECOLOGIC ONCOLOGY
- Payer perspectives on pharmacogenomics testing and drug development
- (2008) Robert S Epstein et al. PHARMACOGENOMICS
- Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
- (2008) Margaret L. Holland et al. VALUE IN HEALTH
- The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer
- (2008) Josh J. Carlson et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search